"We had never heard of either of these conditions before, and finding out he had both was so difficult to digest." ...

Agamree secured approvals from various nations for Duchenne muscular dystrophy treatment. Credit: MY STOCKERS/Shutterstock.com. Health Canada has approved Santhera Pharmaceuticals’ Agamree (vamorolone ...

MISSISSAUGA, ON, Oct. 2, 2025 /PRNewswire/ - Kye Pharmaceuticals ("Kye") announced today that Health Canada has approved AGAMREE® (vamorolone) for the treatment of Duchenne Muscular Dystrophy (DMD) in ...

- Data to highlight latest long-term preclinical efficacy and durability data supporting PBGENE-DMD for the treatment of Duchenne Muscular Dystrophy- - On track to file an IND and/or CTA by the end of ...

Between classes at Penn and DJ gigs, Yuva Gambhir manages the rare degenerative disease with grit and determination.

Monday will mark seven years since 11 lives were taken inside Pittsburgh's Tree of Life Synagogue, and each year since, volunteers step up to help and serve the community as a way of honoring them.

A confessed workaholic, Kyambadde admits that he has never taken a leave of absence from his job. His wife, Sylvia Mirembe, ...

A London, Ont., father who has dedicated his life to raising money for a cure to the disease that took his son's life is ...

Colin Lister and Ashley Kirk were told that little baby Joey would be born with some health issues, before he was diagnosed ...

Some children in Northern Ireland who live with a severe form of muscular dystrophy will be able to access new medication on the health service, BBC News understands. The move from the Belfast Health ...

TAKOMA PARK, Md. — Hundreds of people lined up overnight outside Takoma Academy Preparatory School in Takoma Park early ...

Health Canada has approved Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD) in individuals aged four years and above. Agamree is the first approved therapy for ...